Skip to Main Content

Danielle Antin-Ozerkis, MD, BA

DownloadHi-Res Photo
Associate Professor of Medicine (Pulmonary)



Associate Professor of Medicine (Pulmonary)


Dr. Antin-Ozerkis received her Bachelor’s degree from Princeton University. She went on to complete her medical degree, residency, and fellowship in Pulmonary and Critical Care Medicine at the University of Pennsylvania, where she pursued advanced fellowship training in the evaluation and management of advanced lung disease and lung transplant patients. She came to Yale in 2006. Dr. Antin-Ozerkis is Medical Director of the Yale Interstitial Lung Disease Center of Excellence. Her specific area of clinical expertise is the diagnosis and treatment of interstitial lung diseases (ILD), with a focus on idiopathic pulmonary fibrosis (IPF) and connective tissue disease-associated interstitial lung disease (CTD-ILD). She leads a multidisciplinary group which meets weekly to review patient cases, offering consensus opinions on diagnosis and management. As part of a comprehensive approach to patient care, Yale ILD offers clinical drug trials for patients with IPF and other forms of pulmonary fibrosis. Dr. Antin-Ozerkis is the primary investigator at Yale for these studies. She participates in the Center’s translational research program which is aimed at understanding the mechanisms of pulmonary fibrosis development and progression.


Other Departments & Organizations

Education & Training

University of Pennsylvania Health System (2006)
University of Pennsylvania (2002)
University of Pennsylvania Medical School (1999)
Princeton University (1990)


Research at a Glance

Yale Co-Authors

Frequent collaborators of Danielle Antin-Ozerkis's published research.




Clinical Trials

Current Trials

Clinical Care


Danielle Antin-Ozerkis, MD, specializes in the evaluation and management of advanced lung disease. She is the medical director of the Yale Medicine Interstitial Lung Disease Program and cares for patients with all forms of the disease.

“We look for any signs of connective tissue disease and for possible exposures in the workplace and home (such as birds and mold), all of which can lead to interstitial lung disease,” explains Dr. Antin-Ozerkis. “We have a dedicated multidisciplinary group that meets weekly to discuss patient cases and research. Everything we do keeps the focus on the patient. It is so important to get the diagnosis right, as the correct treatment hinges on this. Sometimes the therapy involves new antifibrotic drugs. Other patients may require immunosuppressive therapy. For some, clinical trials are an option. We also focus on quality of life, exercise, oxygen, nutrition and emotional support.”

An associate professor of medicine (pulmonary) at Yale School of Medicine, Dr. Antin-Ozerkis says she enjoys the complexities of pulmonary medicine and the personalized approach involved in treating it. “I love talking with people and trying to understand the reasons they became ill,” she says. “Each time I can sit with a patient and talk with them about their disease in a way that they haven't heard before makes my work feel worthwhile.”

Clinical Specialties

Pulmonology & Sleep Medicine; Pulmonary Critical Care

Fact Sheets

Yale Medicine News

Get In Touch


Academic Office Number
Appointment Number
Office Fax Number
Clinic Fax Number
Mailing Address

Pulmonary, Critical Care & Sleep Medicine

PO Box 208057, 15 York Street

New Haven, CT 06520-8057

United States


  • Academic Office

    Academic Office

    Lippard Laboratory of Clinical Investigation (LLCI)

    15 York Street, Ste 101B

    New Haven, CT 06510

  • Patient Care Locations

    Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.